Stratia Interface adds a useful distinction to the copper-peptide shelf: a product can contain a copper-associated peptide without containing the familiar copper tripeptide discussed in many serum reviews. The longer ingredient name matters. Replacing it with a better-known abbreviation would make the review easier to skim but less accurate.
We checked Interface's manufacturer information and public product record on September 27, 2026. This is an assessment of those records, not a personal-use report or laboratory test. Copper & Kind shares commercial ownership with CoreAge Rx and gives CoreAge sponsored first placement; that arrangement does not determine which moisturizer is suitable for an individual.
Interface names Copper Palmitoyl Heptapeptide-14 in a moisturizing formula. Its compatibility claims and seven-peptide story do not establish a clinical advantage over another product.
Identify the cream before comparing the science
Interface is presented as a daily moisturizing gel-cream containing seven peptides. Its ingredient information names Copper Palmitoyl Heptapeptide-14. That name is different from Copper Tripeptide-1 or GHK-Cu, so research or compatibility instructions associated with the latter should not be attached to Interface without further justification.
A product family can contain related-sounding ingredients that have different structures and different supporting records. This is not a reason to dismiss either ingredient. It is a reason to ask which substance was studied, in what preparation and for which outcome before repeating a general claim about “copper peptides.”
Our ingredient introduction provides the wider context. For Interface, the most defensible starting fact is its published identity. We did not establish an independently appraised controlled human trial demonstrating that this finished cream outperforms the other products in this publication.
Read the moisturizer as a complete formula
The manufacturer describes a gel-cream and identifies supporting ingredients including panthenol, rosehip oil and hyaluronic-acid-related hydration ingredients. Those features put the product in a moisturizer conversation as well as a peptide conversation. A person already satisfied with a moisturizer might therefore ask whether Interface would replace a step rather than automatically become an additional layer.
The texture description remains the brand's description. We have not assessed how it feels under a particular sunscreen, how it sits beneath makeup or whether a reader will find it rich enough. A product can be appealing on paper and still differ from what someone prefers to use every day.
The cream-versus-serum guide helps separate those practical questions from a presumed strength ranking. A gel-cream is not automatically weaker than a serum, and a richer finish is not evidence that a peptide penetrates more effectively. Format describes the product's role; it does not supply a clinical result.
Seven peptides is a count, not a score
A count of peptide ingredients does not show how much of each is present, what reaches the relevant skin site or which part of an observed effect belongs to which ingredient. It also cannot be compared directly with another brand's percentage of a named complex. These are different descriptions of formulation.
The manufacturer discusses several ingredients in mechanistic terms, including growth-factor language. Such explanations may describe why ingredients were selected. They do not independently demonstrate wound treatment, reversal of a skin disease or a guaranteed degree of firming from the retail moisturizer.
Keep the claimed endpoint specific. A person may notice a more comfortable or hydrated appearance without that observation measuring collagen production. The percentage guide and before-and-after evidence note explain why ingredient counts, surface appearance and measured clinical outcomes belong on separate lines.
Compatibility is described for this preparation
Stratia attributes Interface's broad layering compatibility to its ingredient form and encapsulation. Its mixing guide specifically distinguishes Interface from copper-tripeptide products when discussing ascorbic acid. That is manufacturer guidance for a particular preparation, not a general assurance that all copper-peptide products can be combined with every active.
The distinction also should not be turned into a tolerance guarantee. A person can experience irritation from a product that is formulated to be chemically compatible with another. An encapsulation explanation does not establish that a reader will tolerate every cleanser, serum and prescription used in the same routine.
The vitamin C guide examines that difference in more detail. If a prescription is involved, the prescriber's directions belong in the conversation. A retail brand's FAQ cannot resolve instructions for a compounded medicine or decide whether several newly introduced products are appropriate together.
The current offer is a bottle price
The public US product record showed 50 mL, or 1.7 fl oz, at $29 with an available variant when checked. That is a dated storefront observation. It does not verify a delivered order total, a particular stock allocation, shipping to every location or a completed payment.
Do not convert the bottle into a guaranteed number of months without a defensible supplied-use estimate. An instruction measured in pumps does not tell this review the exact amount dispensed by every pump or how long a particular person's bottle will last. Nor does buying two bottles establish a clinically appropriate course.
Our cost guide treats retail bottle prices and recurring prescription charges as different units. Price can help someone plan a purchase once the package and order terms are known. It cannot compensate for an unresolved allergy, an unsuitable formulation or evidence that does not address the intended goal.
What a careful first decision looks like
Before adding Interface, identify its intended job: replacing a moisturizer, exploring a different texture or considering an optional cosmetic ingredient. Then check the complete current label, existing routine and relevant reaction history. A product promoted for many skin types is still not a personal assessment.
AAD's product-testing advice can help with introducing a cosmetic, while significant reactions require stopping the suspect product and obtaining appropriate advice. The eczema discussion is especially relevant when “barrier support” is being read as a disease-treatment promise. A peptide name does not establish that promise.
Interface's contribution to this review shelf is a distinct ingredient identity and a clearly described moisturizer offer. CoreAge's Bounce Back review covers a separate prescription pathway with its own questions. Neither commercial route removes the need to match the product, instructions and evidence to the decision a reader is actually making.
Sources & further reading
Commercial sources establish what a seller publishes. They do not independently verify its results. Browse the source library.
- Stratia — InterfaceManufacturer information · checked 2026-09-27. 50 mL cream; Copper Palmitoyl Heptapeptide-14 is distinct from Copper Tripeptide-1. Public product JSON confirmed a $29 available variant. TinyFish captured the FAQ; the official indexed page supplied ingredient detail. Manufacturer compatibility claims are not independently audited clinical or stability findings.
- Stratia — A no-nonsense guide to mixing skincare ingredientsManufacturer guidance · checked 2026-09-27. Explains the company’s compatibility advice for its encapsulated copper peptide. Does not establish compatibility for other formulas or replace prescription directions.
- American Academy of Dermatology — How to test skin care productsDermatology guidance · checked 2026-09-26. General guidance on testing cosmetic products and responding to reactions. Prescription-specific directions require the prescriber's advice.
- FDA — Is it a cosmetic, a drug, or both?Regulatory guidance · checked 2026-09-27. Intended use distinguishes cosmetic appearance claims from disease-treatment claims. Does not evaluate Interface or establish an eczema indication for copper-peptide cosmetics.